BioDueDiligence

Andrew G.

Professional scientific skeptic and biotech/pharma commentator. Founder and editor of BiotechDueDiligence, providing resources for the biotech enthusiast.

Strategy:
Joined 1/2011

3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here.

Introducing Litepaper, a newsletter by Stocktwits. Your lens into the world of crypto.
Join the conversation.This is where all the magic happens.